Four genes that were differentially methylated in T cells from HCC patients in the discovery cohort were validated by pyrosequencing of T cells DNA in a separate cohort of patients (n = 79) and one gene STAP1 was validated in a third cohort (n = 48). This evidence concerns the gene STAP1 and hepatocellular carcinoma.